Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities

In recent years, there has been an exponential increase in the generation and accessibility of electronic healthcare data, often referred to as “real-world data”. The landscape of data sources has significantly expanded to encompass traditional databases and newer sources such as the social media, w...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Salvatore Crisafulli, Francesco Ciccimarra, Chiara Bellitto, Massimo Carollo, Elena Carrara, Lisa Stagi, Roberto Triola, Annalisa Capuano, Cristiano Chiamulera, Ugo Moretti, Eugenio Santoro, Alberto Eugenio Tozzi, Giuseppe Recchia, Gianluca Trifirò
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2024-03-01
Serie:	Frontiers in Drug Safety and Regulation
Soggetti:	artificial intelligence machine learning pharmacological therapies pharmacovigilance pharmacoepidemiology real-world evidence
Accesso online:	https://www.frontiersin.org/articles/10.3389/fdsfr.2024.1356405/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!